No price history available.
Key financial summary
Financials in TWD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | TWDm | 3,679 | 3,948 | 4,345 | 3,809 | 3,851 | 3,800 | N/A | N/A |
| Operating profit | TWDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | TWDm | 135 | 111 | 170 | -7 | -29 | -30 | N/A | N/A |
| EPS reported | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | TWDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | TWDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | TWDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in TWD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Rossmax International Ltd. is dedicated to creating and delivering a wide array of healthcare products and solutions. Their diverse product lineup includes advanced diagnostic and monitoring devices such as body composition scales, which provide readings for body fat, BMI, lean mass, muscle mass, water ratio, and overall body weight. They also offer various blood pressure monitors, including traditional sphygmomanometers, stethoscopes for internal sound auscultation, portable pulse oximeters for tracking blood oxygen saturation, non-contact infrared thermometers, and blood glucose monitoring systems for diabetes management. The company further extends its offerings to therapeutic and assistive medical equipment. This includes nebulizers for mist-based medication delivery, suction units for removing bodily fluids, aero spacers to enhance aerosolized drug administration, peak flow meters for respiratory function assessment, therapeutic heating pads, and anti-decubitus mattresses. Complementing its hardware, Rossmax provides the Healthstyle app, a unified digital platform enabling users to conveniently track key health metrics like blood pressure, blood glucose, SpO2, weight, and temperature. Rossmax's solutions cater to a broad spectrum of medical fields, including cardiovascular health, diabetes, respiratory conditions, fever management, and wound care. They also offer a specialized range of thermometers, scales, and nebulizers specifically designed for pediatric use. Founded in 1988 and headquartered in Taipei, Taiwan, Rossmax International Ltd. operates with a strong global footprint. The company exports its products and maintains active operations in numerous international markets, spanning Taiwan, Italy, Brazil, Mainland China, Germany, Ukraine, Poland, Iraq, India, the United Kingdom, Japan, and Turkey.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Rossmax International Ltd. (4121.TWO)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Rossmax International Ltd. is dedicated to creating and delivering a wide array of healthcare products and solutions. Their diverse product lineup includes advanced diagnostic and monitoring devices such as body composition scales, which provide readings for body fat, BMI, lean mass, muscle mass, water ratio, and overall body weight. They also offer various blood pressure monitors, including traditional sphygmomanometers, stethoscopes for internal sound auscultation, portable pulse oximeters for tracking blood oxygen saturation, non-contact infrared thermometers, and blood glucose monitoring systems for diabetes management. The company further extends its offerings to therapeutic and assistive medical equipment. This includes nebulizers for mist-based medication delivery, suction units for removing bodily fluids, aero spacers to enhance aerosolized drug administration, peak flow meters for respiratory function assessment, therapeutic heating pads, and anti-decubitus mattresses. Complementing its hardware, Rossmax provides the Healthstyle app, a unified digital platform enabling users to conveniently track key health metrics like blood pressure, blood glucose, SpO2, weight, and temperature. Rossmax's solutions cater to a broad spectrum of medical fields, including cardiovascular health, diabetes, respiratory conditions, fever management, and wound care. They also offer a specialized range of thermometers, scales, and nebulizers specifically designed for pediatric use. Founded in 1988 and headquartered in Taipei, Taiwan, Rossmax International Ltd. operates with a strong global footprint. The company exports its products and maintains active operations in numerous international markets, spanning Taiwan, Italy, Brazil, Mainland China, Germany, Ukraine, Poland, Iraq, India, the United Kingdom, Japan, and Turkey.